We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Perdoceo Education
PRDO
$2.17B
| $6M | 0.06% |
490,160
+207,213
| +73% | +$3.01M |
|
302
Enova International
ENVA
$6.09B
| $5.99M | 0.06% |
365,658
+117,898
| +48% | +$1.89M |
|
|
AJRD
303
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $5.97M | 0.06% |
149,699
+118,514
| +380% | +$4.8M |
|
|
EIGI
304
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $5.94M | 0.06% |
1,034,878
-93,196
| -8% | -$523K |
|
|
CVSA
305
Covista Inc
CVSA
$4.55B
| $5.9M | 0.06% |
240,567
+136,853
| +132% | +$4.42M |
|
306
Texas Capital Bancshares
TCBI
$4.28B
| $5.76M | 0.06% |
185,049
+7,356
| +4% | +$232K |
|
307
Intuit
INTU
$91.1B
| $5.73M | 0.06% |
17,573
+15,367
| +697% | +$4.81M |
|
308
Smith & Wesson
SWBI
$649M
| $5.73M | 0.06% |
368,937
+221,903
| +151% | +$3.92M |
|
309
OFG Bancorp
OFG
$2.21B
| $5.7M | 0.06% |
457,662
-27,516
| -6% | -$361K |
|
|
EGRX
310
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.7M | 0.06% |
134,076
+40,446
| +43% | +$1.77M |
|
311
SITE Centers
SITC
$236M
| $5.62M | 0.06% |
1,000,487
-23,677
| -2% | -$140K |
|
|
RDUS
312
DELISTED
Radius Recycling
RDUS
| $5.62M | 0.06% |
292,192
-21,339
| -7% | -$405K |
|
|
TPC
313
Tutor Perini Cor
TPC
$4.03B
| $5.61M | 0.06% |
503,759
-38,376
| -7% | -$471K |
|
|
ARGO
314
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $5.59M | 0.06% |
+162,293
| New | +$5.66M |
|
|
TMX
315
DELISTED
Terminix Global Holdings, Inc.
TMX
| $5.55M | 0.06% |
+139,292
| New | +$5.49M |
|
316
V2X
VVX
$2.7B
| $5.54M | 0.06% |
145,829
-3,173
| -2% | -$138K |
|
|
MRC
317
DELISTED
MRC Global
MRC
| $5.53M | 0.06% |
1,291,704
-58,234
| -4% | -$335K |
|
318
HF Sinclair
DINO
$16.2B
| $5.5M | 0.06% |
279,255
-24,952
| -8% | -$622K |
|
|
CLR
319
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $5.48M | 0.06% |
446,559
-240,938
| -35% | -$3.91M |
|
320
Molson Coors Class B
TAP
$8.02B
| $5.45M | 0.06% |
+162,520
| New | +$5.86M |
|
321
Herc Holdings
HRI
$4.78B
| $5.43M | 0.06% |
137,172
-19,404
| -12% | -$729K |
|
|
BHVN
322
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.43M | 0.06% |
83,565
+27,230
| +48% | +$1.78M |
|
323
Dorian LPG
LPG
$1.96B
| $5.42M | 0.06% |
676,098
-30,983
| -4% | -$257K |
|
324
TechnipFMC
FTI
$28.6B
| $5.4M | 0.06% |
1,150,968
-120,555
| -9% | -$677K |
|
325
Veeco
VECO
$2.62B
| $5.39M | 0.06% |
462,089
-11,768
| -2% | -$150K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.